🇺🇸 FDA
Pipeline program

Dexmedetomidine

2017[13]

Approved small_molecule completed

Quick answer

Dexmedetomidine for Aged is a Approved program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Peking University Third Hospital
Indication
Aged
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials